跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维康特 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Hepatitis A Vaccine (Human Diploid Cell),Inactivated
Approved
生物制品
Hepatitis A Vaccine (Human Diploid Cell),Inactivated
Merck, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Jul 16, 2020
Approval ID
81u8kAiMN7i
Company
Merck, Inc.
Type
生物制品
Approval Details
Approval Id
81u8kAiMN7i
Approval Number
国药准字SJ20140055
Generic Name
甲型肝炎灭活疫苗(人二倍体细胞)
Generic Name En
Hepatitis A Vaccine (Human Diploid Cell),Inactivated
Trade Name
维康特
Drug Type
生物制品
Dosage Form
注射剂
Strength
25U/0.5ml/支
Reg Date
2020-07-16
Expired Date
2025-07-15
Company Name
Merck, Inc.
Company Address
126 E. Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065, US
Production Company Name
Merck, Inc.
Production Company Address
770 Sumneytown Pike, West Point, PA 19486, US
Company Detail Path
/organization/merck-inc
Production Company Detail Path
/organization/merck-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 16, 2020
Approval ID
81u8kAiMN7i
Type
生物制品
Back to NMPA Approvals
